Parm

Ebola Infects Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR)

NASDAQ:TKMR   None
29 0 0
Today shares of Ebola drug maker Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) are getting slammed by more than 5%. There is news out that recent Ebola cases are going to be treated with a rivals's drug and not Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) product. This decline comes just one day after the stock of Tekmira was taken down by nearly 20%. This has become a popular stock among traders and investors looking to make a fast buck. I am looking to the charts and a great entry level I see to buy this names is right around $21. This is a solid level because there is previous consolidation there and also a gap fill. If you are looking to make money on Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) then have the $21 on your watch list.

If you only read one email again, make sure it comes from the Elite Round Table. Our FREE market emails contain information that can actually make you money. Ask yourself, what email have you read that can do that? Answer = none. Join our list here.
EN English
EN English (UK)
EN English (IN)
DE Deutsch
FR Français
ES Español
IT Italiano
PL Polski
SV Svenska
TR Türkçe
RU Русский
PT Português
ID Bahasa Indonesia
MS Bahasa Melayu
TH ภาษาไทย
VI Tiếng Việt
JA 日本語
KO 한국어
ZH 简体中文
ZH 繁體中文
AR العربية
Home Stock Screener Forex Signal Finder Cryptocurrency Signal Finder Economic Calendar How It Works Chart Features House Rules Moderators Website & Broker Solutions Widgets Stock Charting Library Feature Request Blog & News FAQ Help & Wiki Twitter
Profile Profile Settings Account and Billing My Support Tickets Contact Support Ideas Published Followers Following Private Messages Chat Sign Out